Sort   by:  
 Page size 
UnknownThe Indiana O'Brien Center for Advanced Renal Microscopic Analysis.
Not available
S-EPMC8174807 | biostudies-literature
GenomicsPairs of amino acids at the P- and A-sites of the ribosome predictably and causally modulate translation-elongation rates
Pairs of amino acids at the P- and A-sites of the ribosome predictably and causally modulate translation-elongation rates
PRJNA551280 | ENA
UnknownHepatitis C virus diversification in Argentina: comparative analysis between the large city of Buenos Aires and the small rural town of O'Brien.
Not available
S-EPMC3875501 | biostudies-literature
UnknownIdentifying A- and P-site locations on ribosome-protected mRNA fragments using Integer Programming.
Not available
S-EPMC6472398 | biostudies-literature
TranscriptomicsCultured chicken embryonic hepatocytes (CEH) exposed to linear PFOS (L-PFOS) or technical-grade PFOS (T-PFOS)
Recently it was discovered that the perfluorooctane sulfonate (PFOS) detected in wildlife, such as fish-eating birds, had a greater proportion of linear PFOS (L-PFOS) than the manufactured technical product (T-PFOS), which contains linear and branched isomers. This suggests toxicological studies bas...
ORGANISM(S): Gallus gallus 
2011-10-28 | E-GEOD-33291 | biostudies-arrayexpress
UnknownJohn Richard O'Brien
Not available
S-EPMC1128911 | biostudies-literature
UnknownPairs of amino acids at the P- and A-sites of the ribosome predictably and causally modulate translation-elongation rates.
Not available
S-EPMC8270670 | biostudies-literature
UnknownPsychometric evaluation of the near activity visual questionnaire presbyopia (NAVQ-P) and additional patient-reported outcome items.
Not available
S-EPMC11004101 | biostudies-literature
TranscriptomicsTranscription profiling of CD34 positive mononuclear cells from drug naive, chronic myeloid leukemia (CML) patients to determine an expression signature predictive of a major cytogenic response in CML patients treated with Imatinib.
Newly diagnosed chronic phase chronic myeloid leukemia (CML) patients with a major cytogenetic response (MCyR) after 12 months of imatinib therapy have an excellent long-term outcome, while patients without MCyR have a high progression risk. Since patients with primary cytogenetic resistance may ben...
ORGANISM(S): Homo sapiens 
2009-12-31 | E-GEOD-14671 | biostudies-arrayexpress
UnknownA patient-reported pressure ulcer health-related quality of life instrument for use in prevention trials (PU-QOL-P): psychometric evaluation.
Not available
S-EPMC6288857 | biostudies-literature
Sort   by:  
 Page size